Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_assertion description "[Epidermal growth factor receptor (EGFR) transmembrane glycoprotein has been demonstrated to be overexpressed in pancreatic cancer, and it correlates with more advanced disease, poor survival, and the presence of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_assertion evidence source_evidence_literature NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_assertion SIO_000772 23560505 NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_assertion wasDerivedFrom befree-2016 NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_assertion wasGeneratedBy ECO_0000203 NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1066838.RAp_rMUUbjR6X6YFY9qaqBNwUu2F9tE3nmB5quqdNd5Dc130_provenance.